You are required to be logged in to access the full website
Click here if you have forgotten your username or password
2 October 2023 - Biotechnology company NeuroSense Therapeutics Ltd (Nasdaq: NRSN) declared on Monday that it has decided to end its 'at-the-market' (ATM) equity offering program, effective 4 October 2023.The company, focused on treatments f...
2 October 2023 - Clinical-stage biopharmaceutical company SAB Biotherapeutics (Nasdaq:SABS) announced on Monday a private placement agreement with accredited investors, raising up to USD130m in gross proceeds.This funding will propel the development ...
2 October 2023 - Clinical stage biopharmaceutical company Acurx Pharmaceuticals Inc (NASDAQ:ACXP) announced on Monday the early discontinuation of the Phase 2b clinical trial for its lead antibiotic candidate, ibezapolstat, targeting Clostridioides d...
2 October 2023 - Biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) said on Monday that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review for RP-L201 (marnetegragene...
2 October 2023 - Healthcare data and technology solutions provider Veradigm Inc (NASDAQ: MDRX) and Holmusk, a global leader in behavioral health real-world evidence, on Monday announced a new phase in a strategic collaboration. This development invol...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe